ACET
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
69.93M
39 days until earnings call
ARWR
Price
$32.80
Change
+$1.14 (+3.60%)
Updated
Sep 26 closing price
Capitalization
4.53B
65 days until earnings call
Interact to see
Advertisement

ACET vs ARWR

Header iconACET vs ARWR Comparison
Open Charts ACET vs ARWRBanner chart's image
Adicet Bio
Price$0.84
Change-$0.00 (-0.00%)
Volume$236.44K
Capitalization69.93M
Arrowhead Pharmaceuticals
Price$32.80
Change+$1.14 (+3.60%)
Volume$1.86M
Capitalization4.53B
ACET vs ARWR Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. ARWR commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and ARWR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ACET: $0.84 vs. ARWR: $32.80)
Brand notoriety: ACET: Not notable vs. ARWR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 46% vs. ARWR: 74%
Market capitalization -- ACET: $69.93M vs. ARWR: $4.53B
ACET [@Biotechnology] is valued at $69.93M. ARWR’s [@Biotechnology] market capitalization is $4.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileARWR’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • ARWR’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than ARWR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 6 TA indicator(s) are bullish while ARWR’s TA Score has 3 bullish TA indicator(s).

  • ACET’s TA Score: 6 bullish, 4 bearish.
  • ARWR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ACET is a better buy in the short-term than ARWR.

Price Growth

ACET (@Biotechnology) experienced а +5.69% price change this week, while ARWR (@Biotechnology) price change was +6.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ACET is expected to report earnings on Nov 05, 2025.

ARWR is expected to report earnings on Dec 01, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($4.54B) has a higher market cap than ACET($69.9M). ARWR YTD gains are higher at: 74.468 vs. ACET (-12.682). ARWR has higher annual earnings (EBITDA): -52.51M vs. ACET (-112.08M). ARWR has more cash in the bank: 900M vs. ACET (125M). ACET has less debt than ARWR: ACET (15.4M) vs ARWR (353M). ARWR has higher revenues than ACET: ARWR (573M) vs ACET (0).
ACETARWRACET / ARWR
Capitalization69.9M4.54B2%
EBITDA-112.08M-52.51M213%
Gain YTD-12.68274.468-17%
P/E RatioN/AN/A-
Revenue0573M-
Total Cash125M900M14%
Total Debt15.4M353M4%
FUNDAMENTALS RATINGS
ACET vs ARWR: Fundamental Ratings
ACET
ARWR
OUTLOOK RATING
1..100
1423
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4835
P/E GROWTH RATING
1..100
172
SEASONALITY SCORE
1..100
1450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (41) in the Medical Distributors industry is somewhat better than the same rating for ARWR (100) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than ARWR’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as ARWR (100) in the Biotechnology industry. This means that ACET’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's SMR Rating (97) in the Biotechnology industry is in the same range as ACET (98) in the Medical Distributors industry. This means that ARWR’s stock grew similarly to ACET’s over the last 12 months.

ARWR's Price Growth Rating (35) in the Biotechnology industry is in the same range as ACET (48) in the Medical Distributors industry. This means that ARWR’s stock grew similarly to ACET’s over the last 12 months.

ARWR's P/E Growth Rating (2) in the Biotechnology industry is in the same range as ACET (17) in the Medical Distributors industry. This means that ARWR’s stock grew similarly to ACET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETARWR
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 6 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KWHIY26.300.16
+0.61%
Kawasaki Heavy Industries Ltd.
ASHXF0.22N/A
N/A
Progressive Planet Solutions Inc.
FFXXF2.07N/A
N/A
HELIOS FAIRFAX PARTNERS CORP.
GYUAF23.26N/A
N/A
Gs Yuasa Corp.
PAWH7576.38N/A
N/A
Pennsylvania Warehousing & Safe Deposit Co.

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with SYRE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+0.14%
SYRE - ACET
46%
Loosely correlated
+4.04%
RGNX - ACET
46%
Loosely correlated
+3.10%
IPSC - ACET
45%
Loosely correlated
+4.39%
ARWR - ACET
41%
Loosely correlated
+3.60%
INBX - ACET
40%
Loosely correlated
+2.62%
More

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+3.60%
DNLI - ARWR
52%
Loosely correlated
+3.87%
IMNM - ARWR
50%
Loosely correlated
+14.13%
IPSC - ARWR
48%
Loosely correlated
+4.39%
RGNX - ARWR
48%
Loosely correlated
+3.10%
CRNX - ARWR
48%
Loosely correlated
+27.92%
More